The current financial score of Charles River Laboratories International Inc is 6.54. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.00B, representing a year-over-year decrease of 2.72%, while its net profit experienced a year-over-year decrease of 102.83%.
The current valuation score of Charles River Laboratories International Inc is 9.70. Its current P/E ratio is -74.84, which is -1367.67% below the recent high of 948.76 and -234.91% above the recent low of -250.66.
The current earnings forecast score of Charles River Laboratories International Inc is 7.89. The average price target is 270.39, with a high of 320.00 and a low of 145.81.
The current price momentum score of Charles River Laboratories International Inc is 2.86. Currently, the stock price is trading between the resistance level at 297.02 and the support level at 265.78, making it suitable for range-bound swing trading.
The current institutional shareholding score of Charles River Laboratories International Inc is 10.00. The latest institutional shareholding proportion is 116.51%, representing a quarter-over-quarter decrease of 9.74%.
The current risk assessment score of Charles River Laboratories International Inc is 6.81. The company's beta value is 1.46. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.